Recently Nihon Keizai Shimbun Electronic Edition reported
the following:
英アストラゼネカ、ワクチン生産能力倍増 20億回分に
新型コロナ ヨーロッパ
2020/6/5 5:07
【ロンドン=佐竹実】英製薬大手のアストラゼネカは4日、英オックスフォード大学と開発する新型コロナウイルスのワクチンについて、今年から来年にかけて20億回分の生産が可能になるとの見通しを発表した。インドの大手ワクチンメーカーと新たにライセンス契約を結び、従来の生産計画から倍増する。
Translation
[London = Minoru Satake] On April 4, AstraZeneca, a major
British pharmaceutical company, announced that it might be able to produce 2
billion doses of new coronavirus vaccine to be developed with the Oxford
University in the UK from this year to next year. A new license agreement would
be signed with a major vaccine manufacturer in India to double the existing
production plan.
By signing a license agreement with Serum Institute of India, a major vaccine company in India, it was now possible to produce 1 billion new doses for emerging countries. Of this, the aim was that 400 million would be supplied within this year.
The new corona was spreading in Latin America and other
countries, and the death toll in the world continued to increase. AstraZeneca would
work with international organizations such as the World Health Organization
(WHO) to establish a system to deliver vaccines to emerging countries. Vaccines
were expected to serve as a measure against the new corona, but there was
concern that their supplies might be biased towards the developed countries that
had the financial resources.
So,
vaccine will be ready before the end of this year. I like to hear that.
沒有留言:
張貼留言